Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study

Psychopharmacology

Volumn 216, Issue 4, 2011, Pages 475-484

  Guo, Xiaofeng ^a   Fang, Maosheng ^a,b   Zhai, Jinguo ^a   Wang, Bo ^c   Wang, Chuanyue ^d   Hu, Bin ^e   Sun, Xueli ^f   Lv, Luxian ^g   Lu, Zheng ^h   Ma, Cui ⁱ   Guo, Tiansheng ^j   Xie, Shiping ^k   Twamley, Elizabeth W ^l   Jin, Hua ^l   Zhao, Jingping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SHANDONG MENTAL HEALTH CENTER   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Psychiatric Hospital of Jiangxi Province   (China)

^f SICHUAN UNIVERSITY   (China)

^g Mental Hospital of Henan Province   (China)

^h SHANGHAI MENTAL HEALTH CENTER   (China)

ⁱ Guangzhou Brain Hospital   (China)

^j Hunan Brain Hospital   (China)

^k NANJING MEDICAL UNIVERSITY   (China)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Antipsychotic; Safety; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GLOBAL ASSESSMENT SCALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERSOMNIA; INSIGHT AND TREATMENT ATTITUDES QUESTIONNAIRE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MONOTHERAPY; NATURALISTIC INQUIRY; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; QUESTIONNAIRE; RATING SCALE; RELAPSE; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SIDE EFFECT; SOMNOLENCE; URINARY HESITANCY; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RECURRENCE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79961173861     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2242-3     Document Type: Article

References (35)

1. M Bertelsen P Jeppesen L Petersen A Thorup J ∅hlenschlaeger P le Quach T∅ Christensen G Krarup P Jørgensen M Nordentoft 2008 Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. The OPUS trial Arch Gen Psychiatry 65 7 762 771 18606949 10.1001/archpsyc.65.7.762 (Pubitemid 351957702)
2. Bortz J, Lienert GA, Boehnke K (1990) Verteilungsfreie Methoden in der Biostatistik. Springer, Berlin
3. MN Brunden 1972 The analysis of non-independent 2×2 tables using rank sums Biometrics 28 603 607 10.2307/2556175
4. WK Chrzanowski RN Marcus A Torbeyns M Nyilas RD McQuade 2006 Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine Psychopharmacology (Berl) 189 2 259 266 10.1007/s00213-006-0564- 3 1:CAS:528:DC%2BD28XhtFKgu7jF (Pubitemid 44691547)
5. JG Csernansky R Mahmoud R Brenner 2002 A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia N Engl J Med 346 1 16 22 11777998 10.1056/NEJMoa002028 1:CAS:528:DC%2BD38XnvVSk (Pubitemid 34438915)
6. M Dossenbach C Arango-Dávila H Silva Ibarra E Landa J Aguilar O Caro J Leadbetter S Assunção 2005 Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the intercontinental schizophrenia outpatient health outcmes (IC-SOHO) study J Clin Psychiatry 66 8 1021 1030 16086618 10.4088/JCP.v66n0810 1:CAS:528:DC%2BD2MXhtVagsrzM (Pubitemid 41191795)
7. J Endicott RL Spitzer JL Fleiss J Cohen 1976 The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch Gen Psychiatry 33 6 766 771 938196 1:STN:280:DyaE283jtVOkug%3D%3D
8. W Gaebel M Riesbeck W Wölwer A Klimke M Eickhoff M von Wilmsdorff MC Jockers-Scherübl KU Kühn M Lemke A Bechdolf S Bender D Degner R Schlösser LG Schmidt A Schmitt M Jäger G Buchkremer P Falkai S Klingberg W Köpcke W Maier H Häfner C Ohmann HJ Salize F Schneider HJ Möller 2007 Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia J Clin Psychiatry 68 11 1763 1774 18052570 10.4088/JCP.v68n1116 1:CAS:528:DC%2BD2sXhsVyjsbjK (Pubitemid 350247506)
9. Guy W (1976a) ECDEU Assessment manual for psychopharmacology, revised. US Department of Health, Education, and Welfare, Rockville. pp 76-338
10. Guy W (1976b) ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare, Rockville. pp 583-585
11. Guy W (1976c) ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare, Rockville. pp 341-350
12. JM Haro D Novick D Suarez J Alonso JP Lépine M Ratcliffe 2006 Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study J Clin Psychopharmacol 26 6 571 578 17110813 10.1097/01.jcp.0000246215.49271.b8 (Pubitemid 44772733)
13. RS Kahn WW Fleischhacker H Boter M Davidson Y Vergouwe IP Keet MD Gheorghe JK Rybakowski S Galderisi J Libiger M Hummer S Dollfus JJ López-Ibor LG Hranov W Gaebel J Peuskens N Lindefors A Riecher-Rössler DE Grobbee EUFEST study group 2008 Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial Lancet 371 9618 1085 1097 18374841 10.1016/S0140-6736(08)60486-9 1:CAS:528:DC%2BD1cXktVCns7c%3D (Pubitemid 351418005)
14. J Kane G Honigfeld J Singer H Meltzer 1988 Clozapine for treatment-resistant schizophrenia Arch Gen Psychiatry 45 789 796 3046553
15. S Kasper MN Lerman RD McQuade A Saha WH Carson M Ali D Archibald G Ingenito R Marcus 2003 Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia Int J Neuropsychopharmacol 6 4 325 337 14609439 10.1017/S1461145703003651 1:CAS:528:DC%2BD3sXpsFOnu7g%3D (Pubitemid 38146250)
16. SR Kay A Fiszbein LA Opler 1987 The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 2 261 276 3616518 (Pubitemid 18039085)
17. BJ Kinon H Liu-Seifert DH Adams L Citrome 2006 Differential rates of treatment discontinuation in clinical trials as comparator atypical antipsychotics for schizophrenia J Clin Psychopharmacol 26 6 632 637 17110821 10.1097/01.jcp.0000245563.06660.0f 1:CAS:528:DC%2BD28Xht1Smt7nO (Pubitemid 44772741)
18. S Leucht C Corves D Arbter RR Engel C Li JM Davis 2009 Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Lancet 373 9657 31 41 19058842 10.1016/S0140-6736(08)61764-X 1:CAS:528:DC%2BD1MXht1Wqsw%3D%3D
19. S Leucht K Komossa C Rummel-Kluge C Corves H Hunger F Schmid C Asenjo Lobos S Schwarz JM Davis 2009 A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia Am J Psychiatry 166 2 152 163 19015230 10.1176/appi.ajp.2008.08030368
20. JA Lieberman G Tollefson M Tohen AI Green RE Gur R Kahn J McEvoy DO Perkins T Sharma R Zipursky H Wei R Hamer 2003 Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol Am J Psychiatry 160 8 1396 1404 12900300 10.1176/appi.ajp.160.8.1396 (Pubitemid 41070913)
21. JA Lieberman M Phillips H Gu S Stroup P Zhang L Kong Z Ji G Koch RM Hamer 2003 Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine Neuropsychopharmacology 28 5 995 1003 12700715 1:CAS:528:DC%2BD3sXjsVGqu78%3D
22. JA Lieberman TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins RS Keefe SM Davis CE Davis BD Lebowitz J Severe JK Hsiao CA Trials Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators 2005 Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 12 1209 1223 16172203 10.1056/NEJMoa051688 1:CAS:528: DC%2BD2MXhtVeltL%2FN (Pubitemid 41345943)
23. PX Mao YL Tang ZM Wang F Jiang CF Gillespie ZJ Cai 2007 Antipsychotic drug use in 503 Chinese in patients with schizophrenia Int J Psychiatry Clin Pract 11 1 29 35 10.1080/13651500600874360 1:CAS:528:DC%2BD2sXkvVOgs78%3D (Pubitemid 46393137)
24. SR Marder SM Glynn WC Wirshing DA Wirshing D Ross C Widmark J Mintz RP Liberman KE Blair 2003 Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes Am J Psychiatry 160 8 1405 1412 12900301 10.1176/appi.ajp.160.8.1405 (Pubitemid 41070914)
25. JL Martin V Pérez M Sacristán F Rodríguez-Artalejo C Martínez E Alvarez 2006 Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia Eur Psychiatry 21 1 11 20 16380237 10.1016/j.eurpsy.2005.09.009 (Pubitemid 43243048)
26. S Miyamoto GE Duncan CE Marx JA Lieberman 2005 Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol Psychiatry 10 1 79 104 15289815 10.1038/sj.mp.4001556 1:CAS:528:DC%2BD2cXhtFeisL3M (Pubitemid 40139590)
27. JP McEvoy JA Lieberman DO Perkins RM Hamer H Gu A Lazarus D Sweitzer C Olexy P Weiden SD Strakowski 2007 Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison Am J Psychiatry 164 1050 1060 17606657 10.1176/appi.ajp.164.7.1050 (Pubitemid 47121394)
28. JP McEvoy LJ Apperson PS Appelbaum P Ortlip J Brecosky K Hammill JL Geller L Roth 1989 Insight in schizophrenia: Its relationship to acute psychopathology J Nerv Ment Dis 177 1 43 47 2562850 10.1097/00005053-198901000- 00007 1:STN:280:DyaL1M%2FotVGlsQ%3D%3D (Pubitemid 19043858)
29. JP McEvoy JA Lieberman TS Stroup SM Davis HY Meltzer RA Rosenheck MS Swartz DO Perkins RS Keefe CE Davis J Severe JK Hsiao CATIE Investigators 2006 Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment Am J Psychiatry 163 4 600 610 16585434 10.1176/appi.ajp.163.4.600 (Pubitemid 44464569)
30. TM Si L Shu X Yu C Ma GH Wang PS Bai XH Liu LP Ji JG Shi XS Chen QY Mei KQ Su HY Zhang H Ma 2004 Antipsychotic drug patterns of schizophrenia in china: a cross-sectioned study Chin J Psychiatry [in Chinese] 37 3 152 155
31. GM Simpson JWS Angus 1970 A rating scale for extrapyramidal side effects Acta Psychiatr Scand 212 Suppl 11 19 10.1111/j.1600-0447.1970.tb02066.x 1:STN:280:DyaE3c3ptFWjuw%3D%3D
32. TS Stroup JA Lieberman JP McEvoy MS Swartz SM Davis RA Rosenheck DO Perkins RS Keefe CE Davis J Severe JK Hsiao CATIE Investigators 2006 Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic Am J Psychiatry 163 4 611 622 16585435 10.1176/appi.ajp.163.4.611 (Pubitemid 44464570)
33. TS Stroup JA Lieberman JP McEvoy MS Swartz SM Davis GA Capuano RA Rosenheck RS Keefe AL Miller I Belz JK Hsiao CATIE Investigators 2007 Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study Am J Psychiatry 164 3 415 427 17329466 10.1176/appi.ajp.164.3.415 (Pubitemid 46513155)
34. TS Stroup JA Lieberman JP McEvoy SM Davis MS Swartz RS Keefe AL Miller RA Rosenheck JK Hsiao CATIE Investigators 2009 Results of phase 3 of the CATIE schizophrenia trial Schizophr Res 107 1 1 12 19027269 10.1016/j.schres.2008.10. 011
35. RR Wu JP Zhao ZN Liu JG Zhai XF Guo WB Guo JS Tang 2006 Effect of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia Psychopharmacology (Berl) 184 4 572 578 10.1007/s00213-006-0384-5 (Pubitemid 43855844)